오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 75 microgram - tablet, uncoated - excipient ingredients: light magnesium oxide; sodium stearylfumarate; sodium starch glycollate; microcrystalline cellulose; allura red ac aluminium lake; indigo carmine aluminium lake - levothox is indicated for the management of demonstrated thyroid hormone deficiency.,levothox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - levothyroxine sodium, quantity: 75 microgram - tablet - excipient ingredients: gelatin; lactose monohydrate; maize starch; croscarmellose sodium; magnesium stearate - levothyroxine sandoz is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine sandoz is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - levothyroxine sodium, quantity: 50 microgram - tablet - excipient ingredients: gelatin; lactose monohydrate; maize starch; croscarmellose sodium; magnesium stearate - levothyroxine sandoz is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine sandoz is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - levothyroxine sodium, quantity: 200 microgram - tablet - excipient ingredients: lactose monohydrate; gelatin; maize starch; croscarmellose sodium; magnesium stearate - levothyroxine sandoz is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine sandoz is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - levothyroxine sodium, quantity: 100 microgram - tablet - excipient ingredients: lactose monohydrate; gelatin; maize starch; croscarmellose sodium; magnesium stearate - levothyroxine sandoz is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine sandoz is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.075 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; dextrin; maize starch - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.075 mg - tablet, uncoated - excipient ingredients: magnesium stearate; dextrin; maize starch; lactose monohydrate - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: magnesium stearate; dextrin; lactose monohydrate; maize starch - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.1 mg - tablet, uncoated - excipient ingredients: dextrin; maize starch; magnesium stearate; lactose monohydrate - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.05 mg - tablet, uncoated - excipient ingredients: dextrin; maize starch; lactose monohydrate; magnesium stearate - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.